Accelerate your drug discovery programs with Arontier's platform combining AI and physics-based approaches. From small molecules to antibodies, peptides, and proteins — delivering experimentally validated results.
Biologics Design
Structure-guided design for antibodies, peptides, and proteins — delivering experimentally validated hits with minimal wet-lab burden.
AI-powered large-scale virtual screening: 100M compounds in 72 hours. Reverse target screening across 18,000+ proteins and integrated in silico ADMET profiling with 30+ AI models.
Integrated AI + physics-based platform enabling atomic-level understanding and optimization. Arontier's core technology for structure-based therapeutic discovery and design.